Reduction of MRSA populations and Aeroallergens on using AHPCO® and Plasma Nanotechnology for Air Purification
Methicillin-resistant Staphylococcus aureus, MRSA has become a serious public health issue. We implemented
an air purification system using a hybrid AHPCO® and Plasma Nanotechnology that reduced the indoor particulate matters
including all forms of aeroallergen.In this study, the efficiency of Air Oasis air purifiers such as the Xtreme 3000 air purifier,
Wall-Mount and the InductACT air purifiers were evaluated in the Microbiology and Mycologylaboratories of the Baptist
Saint Anthony’s Hospital (BSA) in Amarillo, Texas. This department processes around 85,000 bacterial and fungal cultures
per calendar year, and the staff also performs various types of serological testing for bacterial pathogens and routine
parasitological examinations on various types of clinical specimens. We evaluated the efficiency of the net reduction of
bacteria in a negative pressure laboratory and the specific effect on isolates identified as Methicillin-resistant Staphylococcus
aureus (MRSA). The air purification system with novel AHPCO®and Plasma nanotechnology reduced the concentration of
MRSA, Fungi and the other indoor particulate matters gradually with varied time intervals.
Index Terms - Air Purifiers, AHPCO®, Plasma Nanotechnology,MRSA, Staphylococcus aureus.